• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Ebola

Funding cuts delayed Ebola vaccine, U.S. official says

By
TIME
TIME
Down Arrow Button Icon
By
TIME
TIME
Down Arrow Button Icon
October 13, 2014, 8:25 AM ET
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
An employee operates machinery to arrange Duloxetine delayed-release capsules for packaging inside the packaging unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India, on Friday, Feb. 7, 2014. Lupin, founded by billionaire Desh Bandhu Gupta, expects to gain share in the U.S. amid increased regulatory oversight and curbs on competitors including Ranbaxy Laboratories Ltd. Photographer: Dhiraj Singh/Bloomberg via Getty ImagesPhotograph by Dhiraj Singh — Bloomberg/Getty Images

This post is in partnership with Time. The article below was originally published at Time.com

By Maya Rhodan, TIME

Researchers might have developed an Ebola vaccine in time to stem the current outbreak if it weren’t for budget cuts, a top federal health official said in a new interview.

Francis Collins, the head of the National Institutes of Health, said the agency has been working on Ebola vaccines since 2001. “It’s not like we suddenly woke up and thought, ‘Oh my gosh, we should have something ready here,’” Collins told the Huffington Post. “Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would’ve gone through clinical trials and would have been ready.”

Collins said researchers and doctors would likely have been “a year or two ahead of where we are” had research funding stayed on track.

His comments come as officials are dealing with the second case of the deadly disease to be diagnosed in the United States The death toll from the outbreak, which has ravaged countries in West Africa, recently surpassed 4,000.

[Huffington Post]

About the Author
By TIME
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.